DEXCOM, INC. SEC Schedule, 12-09, Valuation Allowances and Reserves, Addition, Recovery
DEXCOM, INC. (DXCM) reported SEC Schedule, 12-09, Valuation Allowances and Reserves, Addition, Recovery of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Notes › Valuation and Qualifying Accounts
us-gaap:ValuationAllowancesAndReservesRecoveries · last filed 2026-02-12
- DEXCOM, INC. sec schedule, 12-09, valuation allowances and reserves, addition, recovery for fiscal 2025 was $0.00.
- DEXCOM, INC. sec schedule, 12-09, valuation allowances and reserves, addition, recovery for fiscal 2024 was $0.00.
- DEXCOM, INC. sec schedule, 12-09, valuation allowances and reserves, addition, recovery for fiscal 2023 was $0.00.
- DEXCOM, INC. sec schedule, 12-09, valuation allowances and reserves, addition, recovery for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Addition, Recovery 12 month | SEC Schedule, 12-09, Valuation Allowances and Reserves, Addition, Recovery 12 month as first filed |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-12 | |
| 2024-12-31 | $0.00 10-K · filed 2026-02-12 | |
| 2023-12-31 | $0.00 10-K · filed 2026-02-12 | |
| 2022-12-31 | $0.00 10-K · filed 2025-02-18 | |
| 2021-12-31 | $100.00K 10-K · filed 2024-02-08 | |
| 2020-12-31 | $300.00K 10-K · filed 2023-02-09 | |
| 2019-12-31 | $700.00K 10-K · filed 2022-02-14 | |
| 2018-12-31 | $500.00K 10-K · filed 2021-02-11 | |
| 2017-12-31 | $700.00K 10-K · filed 2020-02-13 | |
| 2016-12-31 | $700.00K 10-K · filed 2019-02-21 | |
| 2015-12-31 | $200.00K 10-K · filed 2018-02-27 | |
| 2014-12-31 | $300.00K 10-K · filed 2017-02-28 | |
| 2013-12-31 | $100.00K 10-K · filed 2016-02-23 | |
| 2012-12-31 | $100.00K 10-K · filed 2015-02-25 | |
| 2011-12-31 | $100.00K 10-K · filed 2014-02-20 | $75.00K 10-K · filed 2012-02-23 |
| 2010-12-31 | $0.00 10-K · filed 2013-02-21 | $6.00K 10-K · filed 2012-02-23 |
| 2009-12-31 | $0.00 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |